腋窝手术与区域淋巴结放疗对乳腺癌相关淋巴水肿及局部肿瘤控制的影响:前瞻性筛查试验长期结果
该前瞻性筛查试验纳入2005至2018年1815例浸润性乳腺癌患者,按腋窝手术方式分为SLNB alone、SLNB+RLNR、ALND alone、ALND+RLNR四组,用perometer客观评估肢体体积,淋巴水肿定义为术后>3个月手臂体积相对增加≥10%。主要终点为各组BCRL率,次要终点为5年局部区域控制和DFS。结果显示ALND+RLNR、ALND alone、SLNB+RLNR、SLNB alone的5年BCRL累积发生率分别为30.1%、24.9%、10.7%、8.0%。
要点
- 各组5年局部区域控制率相似(ALND+RLNR 2.8%、ALND alone 3.8%、SLNB+RLNR 0%、SLNB alone 2.3%)。
核心结论
- 尽管RLNR增加淋巴水肿风险,但腋窝手术类型是BCRL的主要风险因素。
- 各组5年局部区域控制率相似。
研究设计与样本
- 2005至2018年前瞻性淋巴水肿筛查试验,纳入1815例浸润性乳腺癌患者。
- 按腋窝手术方式分为SLNB alone(1340例)、SLNB+RLNR(121例)、ALND alone(91例)、ALND+RLNR(263例)四组。
- 用perometer客观评估肢体体积,淋巴水肿定义为术后>3个月手臂体积相对增加≥10%。
- 主要终点为各组BCRL率,次要终点为5年局部区域控制和DFS。
- 全队列诊断后中位随访时间52.7个月。
主要发现
- ALND+RLNR、ALND alone、SLNB+RLNR、SLNB alone的5年BCRL累积发生率分别为30.1%、24.9%、10.7%、8.0%。
- ALND+RLNR、ALND alone、SLNB+RLNR、SLNB alone的5年局部区域控制率分别为2.8%、3.8%、0%、2.3%。
关键数值与推荐
- 淋巴水肿定义:术后>3个月手臂体积相对增加≥10%。
- 5年BCRL累积发生率:ALND+RLNR 30.1%、ALND alone 24.9%、SLNB+RLNR 10.7%、SLNB alone 8.0%。
- 5年局部区域控制率:ALND+RLNR 2.8%、ALND alone 3.8%、SLNB+RLNR 0%、SLNB alone 2.3%。
临床怎么用
- 临床决策应重视腋窝手术方式对BCRL风险的影响,ALND alone者BCRL风险显著高于SLNB+RLNR。
- RLNR虽增加淋巴水肿风险,但在ALND基础上未显著进一步增加BCRL风险。
- 各组5年局部区域控制率相似,支持在合适患者中权衡手术降阶与淋巴水肿风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To independently evaluate the impact of axillary surgery type and regional lymph node radiation (RLNR) on breast cancer-related lymphedema (BCRL) rates in patients with breast cancer. PATIENTS AND METHODS: From 2005 to 2018, 1,815 patients with invasive breast cancer were enrolled in a lymphedema screening trial. Patients were divided into the following 4 groups according to axillary surgery approach: sentinel lymph node biopsy (SLNB) alone, SLNB+RLNR, axillary lymph node dissection (ALND) alone, and ALND+RLNR. A perometer was used to objectively assess limb volume. All patients received baseline preoperative and follow-up measurements after treatment. Lymphedema was defined as a ≥ 10% relative increase in arm volume arising > 3 months postoperatively. The primary end point was the BCRL rate across the groups. Secondary end points were 5-year locoregional control and disease-free-survival. RESULTS: The cohort included 1,340 patients with SLNB alone, 121 with SLNB+RLNR, 91 with ALND alone, and 263 with ALND+RLNR. The overall median follow-up time after diagnosis was 52.7 months for the entire cohort. The 5-year cumulative incidence rates of BCRL were 30.1%, 24.9%, 10.7%, and 8.0% for ALND+RLNR, ALND alone, SLNB+RLNR, and SLNB alone, respectively. Multivariable Cox models adjusted for age, body mass index, surgery, and reconstruction type showed that the ALND-alone group had a significantly higher BCRL risk (hazard ratio [HR], 2.66; P = .02) compared with the SLNB+RLNR group. There was no significant difference in BCRL risk between the ALND+RLNR and ALND-alone groups (HR, 1.20; P = .49) and between the SLNB-alone and SLNB+RLNR groups (HR, 1.33; P = .44). The 5-year locoregional control rates were similar for the ALND+RLNR, ALND-alone, SLNB+RLNR, and SLNB-alone groups (2.8%, 3.8%, 0%, and 2.3%, respectively). CONCLUSION: Although RLNR adds to the risk of lymphedema, the main risk factor is the type of axillary surgery used.
引用
- Naoum GE, Roberts S, Brunelle CL, et al. Quantifying the Impact of Axillary Surgery and Nodal Irradiation on Breast Cancer-Related Lymphedema and Local Tumor Control: Long-Term Results From a Prospective Screening Trial. J Clin Oncol. 2020. PMID: 32730184. doi:10.1200/JCO.20.00459
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。